Howard Berman

Howard Berman

Independent DirectoratCoya Therapeutics· In proxies 2023–2025

Pay in FY2024+103% from the year before · Coya Therapeutics stock -22.7% the same year

Howard Berman was paid $2.7M in FY2024 (Dec), up 103%. Coya Therapeutics stock fell 22.7% that year.

Pay$100 in the stock at the end of FY22 → $121
Pay is from the Summary Compensation Table of each Coya Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Atea PharmaceuticalsPublic company · 2 yr
    • Independent Director2024 – Present · 2 yrNo stock prices for these years
  2. Coya TherapeuticsPublic company · 3 yr
    • Former Chief Executive Officer, Current Executive Chairman of the Board2023 – Present · 3 yrStock in role -14%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?